Google
TTRX — TURN THERAPEUTICS INC. COMMON STOCK (Healthcare >> Biotechnology)
TTRX FAQ
What is TTRX's P/E ratio?
TURN THERAPEUTICS INC. COMMON STOCK (TTRX) currently trades at a P/E ratio of 629.77.
What is TTRX's ROE?
TURN THERAPEUTICS INC. COMMON STOCK reports a Return on Equity (ROE) of -62.71%.
What is TTRX's dividend yield?
TURN THERAPEUTICS INC. COMMON STOCK offers a dividend yield of 0.00%.
What is TTRX's Deepscope Quality Score?
Deepscope rates TTRX's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy TTRX?
Deepscope's AI Timing Score for TTRX is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does TTRX belong to?
TURN THERAPEUTICS INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 5.87
Price
-0.16
(-2.65%)
Day Change
|
|
|---|
TTRX, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
38% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.87 |
| PBV / Sector |
28.73 / 4.92
|
| Earning Per Share | -0.13 |
| PE / Sector |
629.77 / 18.37
|
| PEG or PE/Growth / Sector |
N/A / 0.60
|
| Average 1M Daily Value |
0.38 M
GREAT
|
| Average 1W Daily Value |
0.29 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-06-19 09:46:57 |
| Symbol | TTRX |
| Name | TURN THERAPEUTICS INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 29.79 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 175.75 / 9,037.72 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 250 N Westlake Blvd, Westlake Village, CA, United States, 91362
Phone: 818 546 4011
Website: https://turntherapeutics.com
Sector: Healthcare >> Biotechnology
Description: Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
